Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Redmile Group, LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Colin Walsh - $27.32M of ATTO open-market activity in the last 12 months
- GOLDMAN SACHS GROUP INC - $27.32M of ATTO open-market activity in the last 12 months
- Frazier Life Sciences XI, L.P. - $10.00M of ATTO open-market activity in the last 12 months
- venBio Global Strategic Fund IV, L.P. - $6.50M of ATTO open-market activity in the last 12 months
- Sanofi - $5.10M of ATTO open-market activity in the last 12 months
- EcoR1 Capital, LLC - $4.74M of ATRA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is Redmile Group, LLC?
Redmile Group, LLC is a corporate entity, tracked as 10% Owner of Attovia Therapeutics, Inc. (ATTO). InsiderAlpha holds 18 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Redmile Group, LLC submitted recently?
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Has Redmile Group, LLC been buying or selling stock?
Recorded transactions: 10 open-market purchases ($41.64M) and 9 open-market sales ($20.43M) across all tracked filings.
How accurate is Redmile Group, LLC's historical track record?
Across 8 tracked purchases, Redmile Group, LLC averaged -9.2% avg 30-day return with a 38% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
Where can I see all of Redmile Group, LLC's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Redmile Group, LLC and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
